Analysis of a real practice in hospital pharmacotherapy psoriatic arthritis

The Aim of the study: to define the characteristics of the current treatment of psoriatic arthritis in the settings of specialized medical care in a hospital, based on pharmacoepidemiological study, to optimize the treatment of such patients. Material and Methods. A retrospective pharmacoepidemiological study is based on an analysis of medical records of hospitalized patients rheumatology department requesting assistance in the period from January 2016 to April 2016. Result. As a part of basic anti-inflammatory therapy of psoriatic arthritis, methotrexate was used in 67% patients, sulfasalazine in 25% patients, and cyclosporine and D-penicillamine in 4% patients. Genetically engineered biologic drugs (GEBD) were not used. The anti-inflammatory therapy in hospital was carried out with glucocorticosteroids in 33% patients, with non-steroidal anti-inflammatory drugs (NSAIDs) in 20% cases and in 47% cases a combination of both was used. Gastroprotective therapy was given to all patients receiving corticosteroids and NSAIDs. Conclusion. The study shows that, the treatment of psoriatic arthritis meets the current recommendations, although there are problems associated with excessive use of corticosteroids and the lack of GEBD.